Latanoprost [clinicaltrials_resource:3ae00ce9dbf5a5f1d085c9ca0b67331a]
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [clinicaltrials:NCT00051142]A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma [clinicaltrials:NCT00051181]Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients [clinicaltrials:NCT00069706]Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension. [clinicaltrials:NCT00140062]Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata [clinicaltrials:NCT00187577]Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension [clinicaltrials:NCT00219596]clinicaltrials:NCT00224289Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure [clinicaltrials:NCT00230763]Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device [clinicaltrials:NCT00283764]A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00287521]A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00293787]A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00293800]Latanoprost Versus Fotil [clinicaltrials:NCT00304785]Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients [clinicaltrials:NCT00308945]A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00311389]Results of Mass Switch From Latanoprost to Travoprost [clinicaltrials:NCT00347126]Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost [clinicaltrials:NCT00347841]Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost [clinicaltrials:NCT00348400]clinicaltrials:NCT0038301924-hour Intraocular Pressure (IOP) Control With Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combination in Open-angle Glaucoma [clinicaltrials:NCT00397241]Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops [clinicaltrials:NCT00402493]Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005% [clinicaltrials:NCT00440141]Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma. [clinicaltrials:NCT00440336]Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma [clinicaltrials:NCT00441883]Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy [clinicaltrials:NCT00442312]Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers [clinicaltrials:NCT00468988]A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00527592]clinicaltrials:NCT00539526clinicaltrials:NCT00541242Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study [clinicaltrials:NCT00567788]Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure. [clinicaltrials:NCT00572455]Circadian Rhythms of Aqueous Humor Dynamics in Humans [clinicaltrials:NCT00572936]Effects of Xal-Ease on Patient Compliance With Xalatan [clinicaltrials:NCT00573638]Comparison of Latanoprost Vs. Timolol [clinicaltrials:NCT00579969]A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension. [clinicaltrials:NCT00595101]Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops [clinicaltrials:NCT00596791]Pharmacological Intervention in Diabetic Retinopathy [clinicaltrials:NCT00619034]Adjunctive Study of AL-37807 Ophthalmic Suspension [clinicaltrials:NCT00620256]clinicaltrials:NCT00638742A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma [clinicaltrials:NCT00647101]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Latanoprost [clinicaltrials_resource:3ae00ce9dbf5a5f1d085c9ca0b67331a]
Bio2RDF identifier
3ae00ce9dbf5a5f1d085c9ca0b67331a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3ae00ce9dbf5a5f1d085c9ca0b67331a
identifier
clinicaltrials_resource:3ae00ce9dbf5a5f1d085c9ca0b67331a
title
Latanoprost
@en
type
label
Latanoprost [clinicaltrials_resource:3ae00ce9dbf5a5f1d085c9ca0b67331a]
@en